Serum ferritin as a candidate diagnostic biomarker of polycystic ovarian syndrome: a meta-analysis

References

• Ahmed, H.H., Fadl, N.N., and Kotob, S.E., 2015. Impact of long term metformin therapy on hepcidin and iron status in type II diabetic patients. International journal of pharmaceutical and clinical research, 7(3), 185–193.
   Google Scholar
• Álvarez-Blasco, F., et al., 2009. Role of haptoglobinin polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS one, 4(5), 1–7.
   Web of Science ®Google Scholar
• Atiomo, W., et al., 2009. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG: an international journal of obstetrics and gynaecology, 116(2), 137–143.
   PubMed Web of Science ®Google Scholar
• Ayonrinde, O.T., et al., 2016. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. Journal of gastroenterology and hepatology (Australia), 31(5), 980–987.
   PubMed Web of Science ®Google Scholar
• Azziz, R., et al., 2006. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of clinical endocrinology and metabolism, 91(11), 4237–4245.
   PubMed Web of Science ®Google Scholar
• Azziz, R., et al., 2009. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and sterility, 91(2), 456–488.
   PubMed Web of Science ®Google Scholar
• Bachman, E., et al., 2010. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. Journal of clinical endocrinology and metabolism, 95(10), 4743–4747.
   PubMed Web of Science ®Google Scholar
• Barth, J.H., Yasmin, E., and Balen, A.H., 2007. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clinical endocrinology, 67(6), 811–815.
   PubMed Web of Science ®Google Scholar
• Conway, G.S., et al., 1992. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical endocrinology, 37(2), 119–125.
   PubMed Web of Science ®Google Scholar
• Cussons, A.J., et al., 2005. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clinical endocrinology, 62(3), 289–295.
   PubMed Web of Science ®Google Scholar
• DerSimonian, R. and Laird, N., 1986. Meta-analysis in clinical trials. Controlled clinical trials, 7(3), 177–188.
   PubMedGoogle Scholar
• DeUgarte, C.M., Bartolucci, A.A., and Azziz, R., 2005. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and sterility, 83(5), 1454–1460.
   PubMed Web of Science ®Google Scholar
• Dokras, A., et al., 2005. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstetrics and gynecology, 106(1), 131–137.
   PubMed Web of Science ®Google Scholar
• Dongiovanni, P., et al., 2011. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. Journal of hepatology, 55(4), 920–932.
   PubMed Web of Science ®Google Scholar
• Dymock, I.W., et al., 1972. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. The American journal of medicine, 52(2), 203–210.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H.F. and Luque-Ramírez, M., 2011. Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome. Fertility and sterility, 95(5), 1730–1736.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H.F. and Millán, J.L.S., 2007. Abdominal adiposity and the polycystic ovary syndrome. Trends in endocrinology and metabolism, 18(7), 266–272.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H.F., 2012. Iron metabolism and the polycystic ovary syndrome. Trends in endocrinology and metabolism: tem, 23(10), 509–515.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H.F., et al., 2005. Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes care, 28(8), 2042–2044.
   PubMed Web of Science ®Google Scholar
• Ezeamama, A.E., et al., 2018. Cognitive deficits and educational loss in children with schistosome infection—a systematic review and meta-analysis. PLOS neglected tropical diseases, 12(1), e0005524.
   PubMed Web of Science ®Google Scholar
• Fernández-Real, J.M., López-Bermejo, A., and Ricart, W., 2002. Cross-talk between iron metabolism and diabetes. Diabetes, 51(8), 2348–2354.
   PubMed Web of Science ®Google Scholar
• Goodarzi, M.O., et al., 2011. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology, 7(4), 219–231.
   PubMed Web of Science ®Google Scholar
• Gözdemir, E., Kaygusuz, I., and Kafali, H., 2013. Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome? Gynecologic and obstetric investigation, 75(3), 196–202.
   PubMed Web of Science ®Google Scholar
• Higgins, J.P. and Deeks, J., 2011. Obtaining standard deviations from standard errors and confidence intervals for group means. In: Cochrane handbook for systematic reviews of interventions. Version, 5.
   Google Scholar
• Higgins, J.P.T. and Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21(11), 1539–1558.
   PubMed Web of Science ®Google Scholar
• Higgins, J.P.T., et al., 2003. Measuring inconsistency in meta-analyses. BMJ: British medical journal, 327(7414), 557–560.
   PubMed Web of Science ®Google Scholar
• Hozo, S.P., Djulbegovic, B., and Hozo, I., 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology, 5, 13.
   PubMedGoogle Scholar
• Jehn, M., Clark, J.M., and Guallar, E., 2004. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes care, 27(10), 2422–2428.
   PubMed Web of Science ®Google Scholar
• Kim, J.W., et al., 2014. Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome. Fertility and sterility, 102(2), 548–554.e2.
   PubMed Web of Science ®Google Scholar
• Ko, P.C., et al., 2015. Serum ferritin levels and polycystic ovary syndrome in obese and nonobese women. Taiwanese journal of obstetrics and gynaecology, 54(4), 403–407.
   PubMed Web of Science ®Google Scholar
• Koperdanova, M. and Cullis, J.O., 2015. Interpreting raised serum ferritin levels. BMJ (clinical research ed.), 351, h3692.
   PubMedGoogle Scholar
• Lau, J., Ioannidis, J.P.A., and Schmid, C.H., 1997. Quantitative synthesis in systematic reviews. Annals of internal medicine, 127(9), 820–826.
   PubMed Web of Science ®Google Scholar
• Lee, B.K., Kim, Y., and Kim, Y.I., 2011. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey. Metabolism: Clinical and experimental, 60(10), 1416–1424.
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez, M., Alpañés, M., and Escobar-Morreale, H.F., 2010. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism. Fertility and sterility, 94(6), 2214–2221.
   PubMed Web of Science ®Google Scholar
• Luque-Ramírez, M., et al., 2011. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. The journal of clinical endocrinology & metabolism, 96(3), 846–852.
   PubMed Web of Science ®Google Scholar
• Mantel, N. and Haenszel, W., 1959. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI: journal of the national cancer institute, 22(4), 719–748.
   PubMed Web of Science ®Google Scholar
• Martínez-García, M.Á., et al., 2009. Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes care, 32(8), 1525–1530.
   PubMed Web of Science ®Google Scholar
• Matharoo-Ball, B., et al., 2007. Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms. Journal of proteome research, 6(8), 3321–3328.
   PubMed Web of Science ®Google Scholar
• Moher, D., et al., 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews, 4(1), 1.
   PubMed Web of Science ®Google Scholar
• Montonen, J., et al., 2012. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia, 55(10), 2613–2621.
   PubMed Web of Science ®Google Scholar
• Nemeth, E., et al., 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306(5704), 2090–2093.
   PubMed Web of Science ®Google Scholar
• Pabalan, N., et al., 2018. Soil-transmitted helminth infection, loss of education and cognitive impairment in school-aged children: a systematic review and meta-analysis. PLoS neglected tropical diseases, 12(1), e0005523.
   PubMed Web of Science ®Google Scholar
• Peterson, J., et al., 2011. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.
   Google Scholar
• Ponka, P., Beaumont, C., and Richardson, D.R., 1998. Function and regulation of transferrin and ferritin. Seminars in hematology, 35(1), 35–54.
   PubMed Web of Science ®Google Scholar
• Rajpathak, S.N., et al., 2009. The role of iron in type 2 diabetes in humans. Biochimica et biophysica Acta – General subjects, 1790(7), 671–681.
   PubMed Web of Science ®Google Scholar
• Sam, A.H., et al., 2013. Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabetic medicine, 30(12), 1495–1499.
   PubMed Web of Science ®Google Scholar
• Seow, K.-M., et al., 2012. Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome. Gynecologic and obstetric investigation, 73(3), 236–241.
   PubMed Web of Science ®Google Scholar
• Sharifi, F., Mazloomi, S., and Mousavinasab, N., 2011. High serum ferritin concentrations in polycystic ovary syndrome is not related to insulin resistance. Iranian journal of diabetes and obesity, 3(11), 47–53.
   Google Scholar
• Suurmond, R., van Rhee, H., and Hak, T., 2017. Introduction, comparison, and validation of meta-essentials: a free and simple tool for meta-analysis. Research synthesis methods, 8(4), 537–553.
   PubMed Web of Science ®Google Scholar
• Taghavi, M., Fatemi, S., and Ayatollahi, H., 2009. Evaluation of body iron stores in non-over weight women with polycystic ovarian syndrome and its correlation with insulin resistance. Iranian journal of endocrinology and metabolism, 10(6), 599–660.
   Google Scholar
• Tuomainen, T.P., et al., 1997. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes care, 20(3), 426–428.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2014. Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats. Diabetes, 63(5), 1506–1518.
   PubMed Web of Science ®Google Scholar
• Xu, X., et al., 2014. Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. BMC women’s health, 14(1), 93.
   PubMedGoogle Scholar
• Yang, J.H., et al., 2015. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome. Taiwanese journal of obstetrics and gynecology, 54(6), 686–692.
   PubMed Web of Science ®Google Scholar
• Yildir, I.C., et al., 2013. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test. Gynecological endocrinology, 29(2), 148–151.
   PubMed Web of Science ®Google Scholar
• Yildiz, B.O., et al., 2003. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. The journal of clinical endocrinology and metabolism, 88(5), 2031–2036.
   PubMed Web of Science ®Google Scholar